Medicus Pharma Ltd (TSE:MDCX) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Medicus Pharma Ltd has successfully closed its $4 million initial public offering in the U.S., with its shares and warrants now trading on Nasdaq. The company plans to use the proceeds to advance its clinical trials for treating basal cell carcinoma and explore other non-melanoma skin diseases. Maxim Group LLC and Brookline Capital Markets managed the offering, with the underwriter partially exercising its overallotment option.
For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.
